Konferenzen  >  Medizin & Gesundheitswesen  >  Pharmakologie und Arzneimittelentwicklung

CHI

In its 23rd year Discovery on Target is the premier event highlighting “hot” drug targets and emerging modalities, technologies and strategies for pursuing those targets. The numerous conferences, symposia, courses and training seminars offer key insights for the successful discovery and development of novel therapeutics, from small molecules to biologics to chimeras and conjugates. The 4 day event covers innovations in target identification and lead generation, which includes cancer therapies, protein degradation, induced proximity, AI/machine learning, membrane proteins, translational models, synthetic biology and other relevant topics. New this year is an increased coverage of GLP-1, MASH and obesity, ADCs and bispecifics and on small molecules targeting DNA.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Onkologie,    Biotechnologie

World High Technology Society

The Annual Congress of International Drug Discovery Science & Technology (IDDST), initiated from 2003, has been successfully organized in Shanghai (China), Beijing (China), Shenzhen (China), Nanjing (China), Haikou (China), Suzhou (China), Xi’an (China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA), Kyoto (Japan), Tokyo (Japan), Amsterdam (the Netherlands), Osaka (Japan) and Budapest (Hungary) and has attracted more than 10000 participants from over 50 countries and regions in the previous 20 years. The 21th IDDST (Europe) will be held during June 18-20, 2025 at Stockholm, Sweden. It continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment.

The 21th IDDST (Europe) will host leading scientists from the academia and industry worldwide, to discuss the latest developments in drug discovery and therapy. The program of the coming conference promises to be very interesting for both basic scientists and executives who are working in the field of drug discovery and other related areas, they will offer complete updates of recent developments and present the latest results in the remarkable separate tracks. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better practice and application.

FDAMap

SOP deficiencies are one of the top 5 findings in FDA audits. The entire Quality Management System (QMS) of an organization could be severely compromised due to SOP defects. Formal written Standard Operating Procedures (SOPs) are required both by the FDA and EMA. Almost every deficiency identified in FDA’s 483s and Warning Letters can be traced back to deficiencies in SOPs at an organization. SOPs are often inadequate, miss important elements, do not contain important tools to increase compliance with the SOPs and, many times, are hard for the personnel who follow them to understand. They are frequently poorly written, communicated, monitored and enforced. This workshop will provide step by step instructions to create SOPs for FDA-regulated organizations.

SOP, Quality Management System, Regulatory Affairs, FDA Regulation, FDA Compliance

Legislation in der Medizin und Pharmakologie,    Translationale Medizin, Klinische Studien

Are you ready to explore the cutting-edge for the future of drug discovery? Mark your calendar for the SciLifeLab Science Summit 2025, an event focusing on novel technologies as drivers to find new modalities for disease intervention and drug innovation for precision medicine. This full-day symposium will bring together leading scientists, industry experts, and innovators to discuss the breakthroughs and challenges in addressing previously inaccessible drug targets. Join us at Aula Medica, Karolinska Institutet, for a packed program featuring high-impact international presentations, panel discussions, and networking opportunities.

Uventia

Join us for the 2nd Cleaning Validation Summit, a premier two-day event dedicated to best practices, regulatory expectations and emerging trends in pharmaceutical cleaning validation. This summit will bring together industry experts, regulatory professionals and practitioners to discuss critical topics, from regulatory guidelines (FDA, EMA, PIC/S) to risk-based cleaning validation strategies.

Tel.: [+420 732 640 977];     Email: info@uventia.com

Cleaning Validation, Containment, Bioprocessing, Aseptic Processing, Regulatory Affairs, Analytical Development, Quality Control, QC, Quality Assurance, QA, Risk Management, Drug, Sterility Assurance

Legislation in der Medizin und Pharmakologie,    Biochemie und Medizinische Chemie, Toxikologie

Virtue Insight

Email: Kavitha@virtueinsight.co.in

outcomes research, health economics, government affairs, pharma, pricing, reimbursement, market access, marketing, payer, heor, evidence, hta

Monash University and University of Konstanz

Several cutting-edge areas in antimicrobial pharmacology are emerging, including systems pharmacology, integrative bioinformatics, molecular dynamic simulations, network analysis and modelling, high-content imaging analysis, whole cell based modelling, machine learning, and mechanism-based PK/PD/TD modelling. They increasingly play important roles in understanding antibacterial killing, bacterial resistance, antibiotic toxicity, and host-pathogen-drug interactions. Integrating these powerful computational approaches will substantially facilitate optimisation of antibiotic use in patients. This conference will focus on these topics.

ICACOMP organisers;     Email: icacompconference@gmail.com

Bioinformatics, Chemoinformatics, Systems Pharmacology, Artificial Intelligence for Drug Design, Pharmacometrics, Molecular Dynamics Simulations, Network Analysis and Modelling, Artificial Intelligence for Antimicrobial Pharmacology

Genomforschung und Bioinformatik,    Pharmakogenomik, Personalisierte Medizin

Converge Nation

Step into the heart of innovation at the 10th Supply Chain & Logistics Nation Conference, happening Oct 21–22, 2025, in New Jersey, USA. Join leading minds from the Healthcare and Pharma sectors as we tackle real-world challenges, spark new opportunities, and explore everything from advanced cold chain logistics, temperature control, and compliance strategies to groundbreaking sustainability practices, warehousing, and inventory management solutions. This isn’t just an event it’s a gathering of visionaries where meaningful conversations and valuable connections shape a smarter, more agile future in biopharma and healthcare logistics.

Tel.: [041987654321];     Email: enquiry@convergenation.com

Global Supply Chain, Risk Management, Cold Chain & Temperature-Sensitive Logistics, Technology, Innovation, and Automation.

Magnus Group

Prepare to immerse yourself in the 5th Edition of the International Vaccines Congress (IVC 2025), taking place from October 23-25, 2025, in the vibrant city of Orlando, Florida, USA! This highly anticipated International Vaccines Congress 2025 will offer a unique hybrid format, seamlessly blending onsite and online experiences to maximize global reach and participation. Dive deep into the latest advancements and transformative trends in vaccine science under the theme: From Discovery to Distribution: The Path of Vaccines.

Tel.: [17029882320];     Email: vaccines@magnusconference.com

CHI

Drug Discovery Chemistry is a dynamic conference and networking event for drug discovery scientists working in pharma, biotech, and academia. One of the few events that reflects the new cross-functional and collaborative nature of drug discovery, our event is comprised primarily of pharma and biotech scientists, as well as key academic thought leaders working in translational research. Discussions of chemical tools and approaches to meet the practical (not theoretical) challenges of drug discovery were front and center.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Virtue Insight

Tel.: [9361957193];     Email: Kavitha@virtueinsight.co.in

Pharmacovigilance, regulatory affairs, Drug Safety, Drug Development, patient safety, RiskManagement, Pharmaceuticals, healthcare

IIT (BHU), Varanasi

Drug Discovery and Translational Healthcare 2025 (DDTH 2025) will be held on December 2-3, 2025, at the School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, India, in collaboration with two prestigious societies, Bioinformatics and Drug Discovery Society (BDDS)" and "Biotechnology Society of India (BSI) ". This two-day event will feature keynote, plenary, and invited lectures by leading scientists and academics, alongside oral and poster presentations by students. The conference will focus on applied bioinformatics and various aspects of translational healthcare. DDTH 2025 aims to offer an exceptional platform for staying up-to-date with the latest research, fostering information exchange, and enabling networking opportunities among researchers. We warmly invite you to submit your posters and register for the conference.

Organizing Chairman/Secretaries;     Tel.: [0000000000];     Email: ddthiitbhuvaranasi@gmail.com

Computer Aided Drug Design/Structure-Based Drug Designing, Biotechnology and Healthcare, Omics and Bioinformatics for healthcare, Protein targets and therapeutic proteins

Banff International Research Station for Mathematical Innovation and Discovery (BIRS)

The vaccine development pipeline is a time, cost and labour-intensive process. Mathematical and computational methods can alleviate challenges related to this intensive process as well as providing further insights into the efficacy and safety of vaccines. These methods are key components of model-informed vaccine development (MIVD) and quantitative systems pharmacology/toxicology (QSP/T). MIVD and QSP/T can be used in tandem to better understand the biological processes and outcomes from vaccination administration, spurring future research. This workshop will strengthen and contribute to the ongoing development of this interdisciplinary community of biologists, mathematicians and vaccinologists.

Angewandte Mathematik (allgem.),    Simulation

American Society for Experimental Neurotherapeutics (ASENT)

ASENT's 2026 Annual Meeting is the premier neuroscience and neurotherapeutics conference where leaders from providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders & innovation centers gather to improve the process of bringing neurotherapeutics to market.

Tel.: [8332731556];     Email: jessica@asent.org

Neurology, Neurotherapeutics, Neuroscience, Biotech, Bioengineering, FDA, NIH, Drug Development, Pipeline Presentations

ELETS Technomedia

The expo will be taking place at Hitex Exhibition Centre from 23rd- 25th April (Thu-Sat) 2026, With the concurrent events Next Gen Pharma Summit and Healthcare Innovation Expo & Summit 2026.It will unite pharmaceutical companies, Drug manufacture, healthcare providers, policymakers, researchers, and technology leaders from around the world on one powerful platform to share knowledge, explore solutions, and foster strategic partnerships.

Tel.: [09560050693];     Email: indiapharmaexpo1@gmail.com

Pharamaceuticals, Healthcare Technologies, Vaccines, Nanotechnology, Smart Molecule

Messen und Ausstellungen,    Medizintechnik

The expo will be taking place t Hitex Exhibition Centre from 23rd- 25th April (Thu-Sat). 2026, with the concurrent events NextGenPharma Summit and Healthcare Innovation Expo & Summit 2026.It will unite pharmaceutical companies,Drug manufacture, healthcare providers, policymakers, researchers, and technology leaders from around the world on one powerful platform to share knowledge, explore solutions, and foster strategic partnerships.

Project Head;     Tel.: [95600 50693];     Email: milan.jena@elets.in

healthcare, science, pharmaceuticals, biotenchnology, nenotechnology, health

Banff International Research Station for Mathematical Innovation and Discovery (BIRS)

The landscape of drug design is rapidly evolving, with computational methods and artificial intelligence (AI) playing an increasingly important role. This workshop aims to explore cutting-edge mathematical approaches that are transforming the field of computational drug design. We will delve into multiscale modeling techniques that bridge the gap between molecular and macroscopic levels, providing a comprehensive understanding of drug interactions and dynamics. Additionally, we will highlight the integration of generative AI and machine learning (ML) algorithms in predicting drug efficacy, optimizing molecular structure, speeding up drug repurposing, understanding potential toxicity, and thus accelerating the drug discovery and development process. By bringing together diverse experts from academia, industry, and innovation support organizations, and adding early career researchers to the mix, this workshop will foster interdisciplinary collaboration and innovation. Participants will gain insights into the latest developments, discuss challenges, and explore future opportunities in the quest for more effective and efficient drug design.

Angewandte Mathematik (allgem.),    Neuronale Netze und Künstliche Intelligenz, Maschinelles Lernen